GB2405334B - Particulate materials - Google Patents
Particulate materialsInfo
- Publication number
- GB2405334B GB2405334B GB0416469A GB0416469A GB2405334B GB 2405334 B GB2405334 B GB 2405334B GB 0416469 A GB0416469 A GB 0416469A GB 0416469 A GB0416469 A GB 0416469A GB 2405334 B GB2405334 B GB 2405334B
- Authority
- GB
- United Kingdom
- Prior art keywords
- particulate materials
- particulate
- materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000011236 particulate material Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0524716A GB2421910A (en) | 2002-04-17 | 2003-04-15 | Method of preparing particulate dihydroergotamine and uses of particulate dihydroergotamine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0208742.7A GB0208742D0 (en) | 2002-04-17 | 2002-04-17 | Particulate materials |
GB0308662A GB2388541B (en) | 2002-04-17 | 2003-04-15 | Aerosol formulations containing a particulate active substance |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0416469D0 GB0416469D0 (en) | 2004-08-25 |
GB2405334A GB2405334A (en) | 2005-03-02 |
GB2405334B true GB2405334B (en) | 2006-02-15 |
Family
ID=34117625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0416469A Expired - Lifetime GB2405334B (en) | 2002-04-17 | 2003-04-15 | Particulate materials |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2405334B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4462983A (en) * | 1976-11-19 | 1984-07-31 | Sandoz Ltd. | Certain ergot peptide alkaloids administered to the nasal mucosa |
WO1995001221A1 (en) * | 1993-07-01 | 1995-01-12 | University Of Bradford | Method and apparatus for the formation of particles |
WO2003008082A1 (en) * | 2001-07-20 | 2003-01-30 | Nektar Therapeutics Uk Limited | Method and apparatus for preparing particles |
-
2003
- 2003-04-15 GB GB0416469A patent/GB2405334B/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4462983A (en) * | 1976-11-19 | 1984-07-31 | Sandoz Ltd. | Certain ergot peptide alkaloids administered to the nasal mucosa |
WO1995001221A1 (en) * | 1993-07-01 | 1995-01-12 | University Of Bradford | Method and apparatus for the formation of particles |
WO2003008082A1 (en) * | 2001-07-20 | 2003-01-30 | Nektar Therapeutics Uk Limited | Method and apparatus for preparing particles |
Also Published As
Publication number | Publication date |
---|---|
GB2405334A (en) | 2005-03-02 |
GB0416469D0 (en) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2401547B (en) | Particulate materials | |
AU2003293294A8 (en) | Uv-stabilised particles | |
GB2387191B (en) | Lightweight particulate materials and uses therefor | |
EP1494693A4 (en) | Cripto-specific antibodies | |
PL375405A1 (en) | Antibodies | |
TWI346656B (en) | Photoactive materials | |
GB0216562D0 (en) | Particulate materials | |
GB0323055D0 (en) | Particulate detector | |
GB0308662D0 (en) | Particulate materials | |
GB2387781A8 (en) | Particulate materials | |
ZA200704988B (en) | Particulate materials | |
GB0210517D0 (en) | Material | |
GB2411649B (en) | Carbonaceous materials | |
GB0319401D0 (en) | Materials | |
GB0329208D0 (en) | Particulate materials | |
GB0226878D0 (en) | Antibodies | |
EP1641965A4 (en) | Single-crystal-like materials | |
GB0219091D0 (en) | Depositing solid materials | |
GB0215958D0 (en) | Ceramic materials | |
GB2405334B (en) | Particulate materials | |
GB0209204D0 (en) | Particulate materials | |
GB0209402D0 (en) | Particulate materials | |
GB0210268D0 (en) | Particulate materials | |
GB0211086D0 (en) | Particulate materials | |
GB0329964D0 (en) | Particulate materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20120614 AND 20120620 |
|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20130620 AND 20130626 |
|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20230414 |